Skip to main content

Research Repository

Advanced Search

Outputs (25)

Significant transcriptional changes in mature daughter Varroa destructor mites during infestation of different developmental stages of honeybees (2020)
Journal Article
Tu, Y., Wu, J., Elsheikha, H. M., Getachew, A., Zhou, C., Zhou, H., & Xu, S. (2020). Significant transcriptional changes in mature daughter Varroa destructor mites during infestation of different developmental stages of honeybees. Pest Management Science, 76(8), 2736-2745. https://doi.org/10.1002/ps.5821

Background: Varroa destructor is considered a major cause of honeybee (Apis mellifera) colony losses worldwide. Although V. destructor mites exhibit preference behavior for certain honeybee lifecycle stages, the mechanism underlying host finding and... Read More about Significant transcriptional changes in mature daughter Varroa destructor mites during infestation of different developmental stages of honeybees.

RHΔgra17Δnpt1 strain of Toxoplasma gondii elicits protective immunity against acute, chronic and congenital toxoplasmosis in mice (2020)
Journal Article
Sun, L., Liang, Q., Elsheikha, H. M., Cao, X., Nie, L., Li, T., …Wang, J. (2020). RHΔgra17Δnpt1 strain of Toxoplasma gondii elicits protective immunity against acute, chronic and congenital toxoplasmosis in mice. Microorganisms, 8(3), Article 352. https://doi.org/10.3390/microorganisms8030352

In the present study, a dense granule protein 17 (gra17) and novel putative transporter (npt1) double deletion mutant of Toxoplasma gondii RH strain was engineered. The protective efficacy of vaccination using RHΔgra17Δnpt1 tachyzoites against acute,... Read More about RHΔgra17Δnpt1 strain of Toxoplasma gondii elicits protective immunity against acute, chronic and congenital toxoplasmosis in mice.

Transcriptional changes in Toxoplasma gondii in response to treatment with monensin (2020)
Journal Article
Zhai, B., He, J., Elsheikha, H. M., Li, J., Zhu, X., & Yang, X. (2020). Transcriptional changes in Toxoplasma gondii in response to treatment with monensin. Parasites and Vectors, 13, Article 84. https://doi.org/10.1186/s13071-020-3970-1

Background: Infection with the apicomplexan protozoan parasite T. gondii can cause severe and potentially fatal cerebral and ocular disease, especially in immunocompromised individuals. The anticoccidial ionophore drug monensin has been shown to have... Read More about Transcriptional changes in Toxoplasma gondii in response to treatment with monensin.

Toxoplasma gondii tkl1 Deletion Mutant Is a Promising Vaccine against Acute, Chronic, and Congenital Toxoplasmosis in Mice (2020)
Journal Article
Wang, J., Liang, Q., Li, T., He, J., Bai, M., Cao, X., …Zhu, X. (2020). Toxoplasma gondii tkl1 Deletion Mutant Is a Promising Vaccine against Acute, Chronic, and Congenital Toxoplasmosis in Mice. Journal of Immunology, 204(6), 1562-1570. https://doi.org/10.4049/jimmunol.1900410

In this study, we generated a tkl1 deletion mutant in the Toxoplasma gondii type 1 RH (RHΔtkl1) strain and tested the protective efficacies of vaccination using RHΔtkl1 tachyzoites against acute, chronic, and congenital T. gondii infections in Kunmin... Read More about Toxoplasma gondii tkl1 Deletion Mutant Is a Promising Vaccine against Acute, Chronic, and Congenital Toxoplasmosis in Mice.